Publication: Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012.
dc.contributor.author | Jimenez-Jorge, S | |
dc.contributor.author | Mateo, S de | |
dc.contributor.author | Pozo, F | |
dc.contributor.author | Casas, I | |
dc.contributor.author | Garcia Cenoz, M | |
dc.contributor.author | Castilla, J | |
dc.contributor.author | Gallardo, V | |
dc.contributor.author | Perez, E | |
dc.contributor.author | Vega, T | |
dc.contributor.author | Rodriguez, C | |
dc.contributor.author | Quinones, C | |
dc.contributor.author | Martinez, E | |
dc.contributor.author | Gimenez, J | |
dc.contributor.author | Vanrell, JM | |
dc.contributor.author | Castrillejo, D | |
dc.contributor.author | Serrano, Mc | |
dc.contributor.author | Ramos, JM | |
dc.contributor.author | Larrauri, A | |
dc.contributor.authoraffiliation | [Jiménez-Jorge,S; Mateo,S de; Larrauri,A] National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain. [Jiménez-Jorge,S; Mateo,S de; García Cenoz,M; Castilla,J; Larrauri,A] Ciber Epidemiología y Salud Pública (CIBERESP), Ministry of Economy and Competitiveness, Institute of Health Carlos III, Madrid, Spain. [Pozo,F; Casas,I] National Centre for Microbiology, World Health Organization National Influenza Centre, Institute of Health Carlos III, Madrid, Spain. [García Cenoz,M; Castilla,J] Instituto de Salud Pública de Navarra, Navarra, Spain. [Gallardo,V; Pérez,E] Servicio de Epidemiología y Salud Laboral. Secretaría General de Salud Pública y Participación. Consejería de Salud de Andalucía, Seville, Spain. [Vega,T; Rodriguez,C] Dirección General de Salud Pública, Consejería de Sanidad de Castilla y León, Valladolid, Spain. [Quinones,C; Martínez,E] Servicio de Epidemiología, Subdirección de Salud Pública de La Rioja, La Rioja, Spain. [Giménez,J; Vanrell,JM] Servicio de Epidemiología, Dirección General de Salut Pública, Mallorca, Baleares, Spain. [Castrillejo,D] Servicio de Epidemiología, Dirección General de Sanidad y Consumo, Consejería de Bienestar Social y Sanidad, Ciudad Autónoma de Melilla, Spain. [Serrano,MC; Ramos,JM] Dirección General de Salud Pública, Servicio Extremeño de Salud, Badajoz, Junta de Extremadura, Spain | es |
dc.date.accessioned | 2013-01-18T10:08:52Z | |
dc.date.available | 2013-01-18T10:08:52Z | |
dc.date.issued | 2012-03-22 | |
dc.description | Journal Article; Research Support, Non-U.S. Gov't; | es |
dc.description.abstract | We present early estimates of influenza vaccine effectiveness (VE) in the population targeted for vaccination, during 25 December 2011 to 19 February 2012. The adjusted VE was 55% (95% CI: 3 to 79) against any type of influenza virus and 54% (95% CI: 1 to 79) against influenza A(H3N2) virus. This suggests a moderate protective effect of the vaccine in the targeted population in a late influenza epidemic with limited match between vaccine and circulating strains. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, García Cenoz M, Castilla J, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill. 2012;17(12):pii=20129. | es |
dc.identifier.essn | 1560-7917 | |
dc.identifier.issn | 1025-496X | |
dc.identifier.pmid | 22490308 | |
dc.identifier.uri | http://hdl.handle.net/10668/745 | |
dc.journal.title | Eurosurveillance : Bulletin Européen sur les Maladies Transmissibles = European Communicable Disease Bulletin | |
dc.language.iso | en | |
dc.publisher | European Centre for Disease Prevention and Control | es |
dc.relation.publisherversion | http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20129 | es |
dc.rights.accessRights | open access | |
dc.subject | Vacunas contra la Influenza | es |
dc.subject | Influenza Vaccines | es |
dc.subject | Efectividad | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged::Aged, 80 and over | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Child | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Child::Child, Preschool | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Female | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Infant | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Infant::Infant, Newborn | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Viruses::Vertebrate Viruses::RNA Viruses::Orthomyxoviridae::Influenzavirus A::Influenza A virus::Influenza A Virus, H3N2 Subtype | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Complex Mixtures::Biological Agents::Vaccines::Viral Vaccines::Influenza Vaccines | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Orthomyxoviridae Infections::Influenza, Human | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Models, Statistical::Logistic Models | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Female | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Sentinel Surveillance | es |
dc.subject.mesh | Medical Subject Headings::Geographicals::Geographic Locations::Europe::Spain | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Young Adult | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adolescent | es |
dc.title | Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Jimenez_EarlyEstimates.pdf
- Size:
- 247.45 KB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado